RL

Ronnie Maxwell Lawrence

OS Orphalan S.A.: 5 patents #1 of 3Top 35%
GL Glaxosmithkline: 2 patents #156 of 646Top 25%
KL King'S College London: 2 patents #44 of 368Top 15%
SL Smithkline Beecham Limited: 2 patents #570 of 1,624Top 40%
NL Nerre Therapeutics Limited: 1 patents #4 of 11Top 40%
GL Glaxo Group Limited: 1 patents #753 of 1,368Top 60%
AL Actimed Therapeutics Limited: 1 patents #4 of 10Top 40%
Overall (All Time): #335,178 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12358861 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use Timothy James Morley, Naseem Amin 2025-07-15
12358862 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use Timothy James Morley, Naseem Amin 2025-07-15
12109192 Organic acid addition salts of S-pindolol Robin Chandra BHATTACHERJEE, Andrew Justin Stewart COATS, Elaine MORTEN, Jaclyn Raeburn, Kiara Marissa LOBATO +1 more 2024-10-08
11584741 Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation Edwin Aret, Alan David Borthwick, Jane Theresa Brown, Jonathan Patrick Thomas Corcoran, Maria Beatriz De Castro Vasconcelos Goncalves +1 more 2023-02-21
11117855 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use Timothy James Morley, Naseem Amin 2021-09-14
11072577 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use Timothy James Morley, Naseem Amin 2021-07-27
10988436 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use Timothy James Morley, Naseem Amin 2021-04-27
10870644 Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation Edwin Aret, Alan David Borthwick, Jane Theresa Brown, Jonathan Patrick Thomas Corcoran, Maria Beatriz de Castro Vasconcelos Goncalves +1 more 2020-12-22
8796269 Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same Andrew Craig, Salima Zarah Ismail 2014-08-05
8093242 Crystalline forms of a pyridine derivative Clare Louise Anderton, David Clapham 2012-01-10
7709677 Process of preparing arylethanoldiamines Jason William Beames Cooke, Bobby Neal Glover, Matthew Jude Sharp, Maria Fumiko Tymoschenko 2010-05-04
7557209 Process for the preparation of (1S,4R)-cis-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol 2009-07-07
7425639 Process Jason William Beames Cooke, Bobby Neal Glover, Matthew Jude Sharp, Maria Fumiko Tymoschenko 2008-09-16
6548523 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties Alan Millar 2003-04-15